Equities

Chaoju Eye Care Holdings Ltd

Chaoju Eye Care Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)3.89
  • Today's Change0.08 / 2.10%
  • Shares traded946.50k
  • 1 Year change-29.01%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Chaoju Eye Care Holdings Limited is a China-based company principally engage in the provision of ophthalmic services and eye care services through hospitals and optical clinics. The Company operates its businesses through two segments. The Consumer Ophthalmic Services segment provides refractive correction (including presbyopia correction), myopia control and provides optical products and services. The Basic Ophthalmic Services segment provides treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases, which may be covered by public health insurance programs. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)1.48bn
  • Net income in HKD247.41m
  • Incorporated2020
  • Employees2.60k
  • Location
    Chaoju Eye Care Holdings LtdBlock A, Shouke Building24/F, East Zone,No. 14 Yard, West3rd Ring South Road, Fengtai DistrictBEIJING ChinaCHN
  • Websitehttp://www.chaojueye.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Honliv Healthcare Management Grp Co Ltd821.96m41.40m1.51bn1.97k35.292.5814.161.840.07140.07141.410.9760.79920.0719.25417,452.804.074.506.918.7319.0523.055.096.260.768412.080.24820.004.508.90-21.73-12.0366.84--
Kindstar Globalgene Technology Inc1.05bn44.62m1.61bn3.13k35.390.484313.361.540.0460.0461.083.370.26169.611.61334,527.400.9858-21.991.27-35.4846.6448.763.77-49.513.586.690.0629---30.246.49-45.29--23.67--
MedSci Healthcare Holdings Ltd377.40m59.49m1.74bn--25.451.2725.354.600.11240.11240.72852.26----------------62.03--15.76----172.010.0041--0.0699--155.11------
EuroEyes International Eye Clinic Ltd714.29m131.24m1.83bn290.0013.921.628.312.570.3950.3952.153.410.433623.28114.792,463,066.008.096.189.197.2046.9745.8118.6614.314.53--0.248--17.0412.4446.6929.9134.24--
Rici Healthcare Holdings Ltd3.23bn393.19m1.84bn9.41k4.691.512.730.57040.24720.24722.030.76590.650345.8010.35343,614.908.733.2416.255.7841.7537.0013.435.930.64715.640.67050.0026.0116.8556.06--2.51--
Town Health International Medical Gp Ltd1.83bn-194.21m1.86bn1.40k--0.5745--1.02-0.0287-0.02870.27060.47870.396324.255.041,310,249.00-3.44-1.21-4.29-1.4427.3829.06-8.68-4.013.161.340.1121--19.3710.32-1,370.26---25.95-13.65
EC Healthcare4.10bn-3.74m2.19bn2.72k--1.173.490.5343-0.0032-0.00323.471.590.76156.2316.481,591,122.000.43157.500.681513.4184.7187.530.566610.240.81441.080.389393.0632.7424.27-64.73-24.2551.5214.87
Mega Genomics Ltd163.52m32.46m2.38bn229.0069.373.4348.7114.540.14470.14470.75322.930.201415.921.01714,071.904.00--4.60--58.36--19.85--5.80--0.07--3.82--270.50------
Chaoju Eye Care Holdings Ltd1.48bn247.41m2.75bn2.60k10.961.057.401.860.35490.35492.133.710.485114.4626.75569,941.407.828.088.809.5645.3543.8116.1215.474.9025.560.077951.5738.3316.7021.9242.68-2.33--
Arrail Group Ltd1.72bn-136.55m3.57bn3.46k--1.9225.142.08-0.2345-0.23453.303.200.496923.7317.73503,559.00-3.98---5.33--17.80---8.00--2.14-16.700.3657---9.23--68.63------
C-Mer Eye Care Holdings Ltd1.92bn62.00m4.09bn3.27k66.012.2013.332.130.04940.04941.531.480.68128.9338.29587,828.903.060.92373.871.1232.1729.954.491.441.7516.840.15445.3311.0934.98383.427.8128.01--
Data as of May 17 2024. Currency figures normalised to Chaoju Eye Care Holdings Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

5.35%Per cent of shares held by top holders
HolderShares% Held
Fullgoal Fund Management Co., Ltd.as of 30 Jun 202315.67m2.21%
Grandeur Peak Global Advisors LLCas of 31 Jan 20246.99m0.99%
Fullgoal Asset Management (HK) Ltd.as of 30 Jun 20234.93m0.70%
HuaAn Fund Management Co., Ltd.as of 30 Jun 20233.18m0.45%
Fiera Capital (UK) Ltd.as of 30 Jun 20233.04m0.43%
Harvest Global Investments Ltd.as of 31 Dec 20211.59m0.23%
JPMorgan Asset Management (China) Co Ltd.as of 30 Jun 2023778.00k0.11%
Manulife Investment Management (Hong Kong) Ltd.as of 31 Oct 2023753.00k0.11%
Dimensional Fund Advisors LPas of 31 Jan 2024612.00k0.09%
SSgA Funds Management, Inc.as of 09 May 2024342.50k0.05%
More ▼
Data from 30 Jun 2023 - 10 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.